Deep Sequencing of Bone Marrow Microenvironments of Patients With Del(5q) Myelodysplastic Syndrome Reveals Imprints of Antigenic Selection as Well as Generation of Novel T Cell Clusters as Response Pattern to Lenalidomide

Haematologica - Italy
doi 10.3324/haematol.2018.208223
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

Unusual Clonal Evolution Involving 5q in a Case of Myelodysplastic Syndrome With Deletion 5q 31 Treated With Lenalidomide

Haematologica
Hematology
2008English

Lenalidomide in 5q Minus Myelodysplastic Syndrome: How Long Is Enough?

Annals of Hematology
MedicineHematology
2009English

Myelodysplastic Syndrome of Del 20q With Plasma Cell Dysplasia

Journal of clinical and experimental hematopathology : JCEH
Medicine
2011English

Cryptic 5q Deletion in a Patient With Myelodysplastic Syndrome

British Journal of Haematology
Hematology
2017English

Karyotypic Analysis of Bone Marrow Cells in Pyodermic Lesions Associated With Myelodysplastic Syndrome

Archives of Dermatology
2008English

Relationship of Treatment-Related Cytopenias and Response to Lenalidomide in Patients With Lower-Risk Myelodysplastic Syndromes

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2008English

Cereblon: A Protein Crucial to the Multiple Functions of Immunomodulatory Drugs as Well as Cell Metabolism and Disease Generation

Journal of Immunology Research
MedicineAllergyImmunology
2017English

The Effect of Lenalidomide on Health-Related Quality of Life in Patients With Lower-Risk Non-Del(5q) Myelodysplastic Syndromes: Results From the MDS-005 Study

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2018English

Targeted Next-Generation Sequencing Is a Sensitive Tool for Differential Diagnosis of Myelodysplastic Syndromes in Bone Marrow Trephines

Journal of Molecular Diagnostics
Forensic MedicinePathologyMolecular Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy